| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_08e00d6c0f225b2092510b9d4c97635d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5254 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-295 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-295
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 |
| filingDate |
2017-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bbd8ba658b91b20e0b55355ea011db6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c47cc070d8d121746c2e6747d2466a59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b6a1c4f424b62c41c968557608c8e91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0be3d52ae87ed51c14bea9aa1afcc6c |
| publicationDate |
2019-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20190021938-A |
| titleOfInvention |
Composition for immune enhancement comprising immune response modulator and cationic liposome and use thereof |
| abstract |
The present invention relates to a novel immunostimulating composition comprising an immunoreaction-modulating substance, and more particularly to a composition for enhancing immunity comprising a lipopolysaccharide (LPS) analog having reduced toxicity and a cationic liposome And to their use. The present invention overcomes the physicochemical instability of liposomes and is advantageous not only in production, transportation and storage, but also as an immune delivery system by improving stability. In addition, the present invention includes both an antigen and an immune response modulating substance and a cationic liposome, thereby exhibiting an enhanced immune enhancing effect as compared with the case of using an immune response modulating substance alone. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022191555-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022003443-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4000603-A4 |
| priorityDate |
2017-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |